"The US Food and Drug Administration (FDA) has approved carbidopa/levodopa enteral suspension (Duopa, AbbVie) for the treatment of motor fluctuations in patients with advanced Parkinson's disease, according to a company news release.
DOSAGE AND ADMINISTRATION
Drug-induced Extrapyramidal Symptoms
Oral: One tablet one to three times daily.
Parkinson's Disease: Oral: The usual beginning dose is one tablet three or four times daily. The dosage should be individualized with the dose titrated upward to a maximum of 8 tablets (16 mg) per 24 hours.
AKINETON (biperiden hydrochloride) Tablets, 2 mg each, white, embossed on one face with a triangle, bisected on the reverse and imprinted with the number "11."
Bottles of 100 - NDC # 49884-693-01
Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Dispense in tight, light-resistant container as defined in USP.
Manufactured for: Par Pharmaceutical, Inc., Spring Valley , New York 10977. Manufactured by: Abbott Laboratories, North Chicago, IL 60064, U.S.A.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 4/13/2009
Additional Akineton Information
Akineton - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.